Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Antibiotic Selection00:57

Antibiotic Selection

55.4K
Overview
55.4K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

264
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
264
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

389
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
389
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

220
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
220
Antimicrobial Proteins01:23

Antimicrobial Proteins

6.7K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
6.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Discovery and Biosynthesis of the Novel Glycotetrapeptide Antibiotic Biffamycin A.

Angewandte Chemie (International ed. in English)·2026
Same author

A platform for CRISPRi-seq in <i>Streptomyces albidoflavus</i>.

mBio·2026
Same author

Antibiotics from rare actinomycetes, beyond the genus Streptomyces.

Current opinion in microbiology·2023
Same author

The N-terminal substrate specificity of the SurE peptide cyclase.

Organic & biomolecular chemistry·2022
Same author

ActinoBase: tools and protocols for researchers working on <i>Streptomyces</i> and other filamentous actinobacteria.

Microbial genomics·2022
Same author

A Standalone β-Ketoreductase Acts Concomitantly with Biosynthesis of the Antimycin Scaffold.

ACS chemical biology·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Sep 22, 2025

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.0K

Antibióticos hechos a pedido

Ryan F Seipke1

  • 1Faculty of Biological Sciences, Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK.

Science (New York, N.Y.)
|May 26, 2022
PubMed
Resumen

Los nuevos antibióticos lipopéptidos ofrecen una solución prometedora contra las bacterias multirresistentes. Estos nuevos compuestos son cruciales para combatir las infecciones que son cada vez más difíciles de tratar con los medicamentos existentes.

Área de la Ciencia:

  • Microbiología
  • Enfermedades infecciosas
  • Farmacología

Sus antecedentes:

  • El aumento de las bacterias multirresistentes representa una amenaza significativa para la salud mundial.
  • Las clases de antibióticos existentes se están volviendo menos efectivas debido a los mecanismos de resistencia.
  • Se necesitan con urgencia nuevas estrategias terapéuticas para combatir las infecciones resistentes.

Objetivo del estudio:

  • Para explorar el potencial de los nuevos antibióticos lipopéptidos.
  • Evaluar su eficacia contra las cepas bacterianas multirresistentes.
  • Identificar nuevos fármacos candidatos para el tratamiento de infecciones bacterianas resistentes.

Principales métodos:

  • Síntesis y caracterización de nuevos compuestos lipopéptidos.

Más Videos Relacionados

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
Site-specific Bacterial Chromosome Engineering: &#934;C31 Integrase Mediated Cassette Exchange (IMCE)
08:21

Site-specific Bacterial Chromosome Engineering: ΦC31 Integrase Mediated Cassette Exchange (IMCE)

Published on: March 16, 2012

15.7K

Videos de Experimentos Relacionados

Last Updated: Sep 22, 2025

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.0K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
Site-specific Bacterial Chromosome Engineering: &#934;C31 Integrase Mediated Cassette Exchange (IMCE)
08:21

Site-specific Bacterial Chromosome Engineering: ΦC31 Integrase Mediated Cassette Exchange (IMCE)

Published on: March 16, 2012

15.7K
  • Pruebas de susceptibilidad in vitro contra un grupo de bacterias multirresistentes.
  • Mecanismo de acción Estudios para comprender cómo los lipopéptidos inhiben el crecimiento bacteriano.
  • Principales resultados:

    • Los antibióticos lipopéptidos recientemente desarrollados demostraron una potente actividad contra una serie de patógenos bacterianos multirresistentes.
    • Las concentraciones mínimas inhibidoras (MIC) fueron significativamente más bajas en comparación con los antibióticos establecidos.
    • Los estudios preliminares sugieren un nuevo mecanismo de acción, que podría eludir las vías de resistencia existentes.

    Conclusiones:

    • Los antibióticos lipopéptidos representan una nueva clase de fármacos prometedores para combatir las infecciones bacterianas multirresistentes.
    • Se requiere más investigación y desarrollo para avanzar estos compuestos hacia la aplicación clínica.
    • Estos hallazgos ofrecen esperanza para abordar el desafío crítico de la resistencia a los antimicrobianos.